"Oral semaglutide 50 mg once daily in overweight and obesity: OASIS 1 trial." The Lancet
If you are using a GLP-1 medication, you may notice changes in appetite and how much you eat
Each component has distinct pharmacokinetic properties, with phentermine having a 20-hour half-life and topiramate extending to 21 hours, supporting twice-daily dosing regimens (Hendricks et al., Obesity, 2014)
Isolation and characterization of a new peroxiredoxin from poplar sieve tubes that uses either glutaredoxin or thioredoxin as a proton donor
Just 1% of eligible patients are currently accessing weight-loss services on the NHS, the Health and Social Care Committee (HSCC) told NHS England and Department of Health and Social Care (DHSC) representatives on 3 June 2026 44
For metabolic health and appetite management, the GLP-1 Probiotic or Pro version makes the most sense